Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):1089-96.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Dipyridamole
Disease-Free Survival
Duodenal Neoplasms
Female
Fluorouracil
Follow-Up Studies
Humans
Leucovorin
Male
Middle Aged
Mitomycin
Neoplasm Recurrence, Local
Pancreatic Neoplasms
Pancreaticoduodenectomy
Radiotherapy Dosage
Radiotherapy, Adjuvant
Time Factors

authors with profiles

Ross Abrams